Cargando…

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant

Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports on the use of ibrutinib in RT. Here, we present a patient who was heavily pretreated for C...

Descripción completa

Detalles Bibliográficos
Autores principales: Master, Samip, Leary, Cheri, Takalkar, Amol, Coltelingam, James, Mansour, Richard, Mills, Glenn M., Koshy, Nebu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498945/
https://www.ncbi.nlm.nih.gov/pubmed/28690529
http://dx.doi.org/10.1159/000477338
_version_ 1783248382219780096
author Master, Samip
Leary, Cheri
Takalkar, Amol
Coltelingam, James
Mansour, Richard
Mills, Glenn M.
Koshy, Nebu
author_facet Master, Samip
Leary, Cheri
Takalkar, Amol
Coltelingam, James
Mansour, Richard
Mills, Glenn M.
Koshy, Nebu
author_sort Master, Samip
collection PubMed
description Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports on the use of ibrutinib in RT. Here, we present a patient who was heavily pretreated for CLL, including allogeneic stem cell transplant, and progressed to RT. She had a mixed response to multi-agent chemotherapy and was started on ibrutinib. She had a complete response for 16 months on single-agent ibrutinib with minimal toxicity.
format Online
Article
Text
id pubmed-5498945
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-54989452017-07-07 Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant Master, Samip Leary, Cheri Takalkar, Amol Coltelingam, James Mansour, Richard Mills, Glenn M. Koshy, Nebu Case Rep Oncol Case Report Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports on the use of ibrutinib in RT. Here, we present a patient who was heavily pretreated for CLL, including allogeneic stem cell transplant, and progressed to RT. She had a mixed response to multi-agent chemotherapy and was started on ibrutinib. She had a complete response for 16 months on single-agent ibrutinib with minimal toxicity. S. Karger AG 2017-06-19 /pmc/articles/PMC5498945/ /pubmed/28690529 http://dx.doi.org/10.1159/000477338 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Master, Samip
Leary, Cheri
Takalkar, Amol
Coltelingam, James
Mansour, Richard
Mills, Glenn M.
Koshy, Nebu
Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
title Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
title_full Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
title_fullStr Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
title_full_unstemmed Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
title_short Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
title_sort successful treatment of richter transformation with ibrutinib in a patient with chronic lymphocytic leukemia following allogeneic hematopoietic stem cell transplant
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498945/
https://www.ncbi.nlm.nih.gov/pubmed/28690529
http://dx.doi.org/10.1159/000477338
work_keys_str_mv AT mastersamip successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant
AT learycheri successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant
AT takalkaramol successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant
AT coltelingamjames successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant
AT mansourrichard successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant
AT millsglennm successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant
AT koshynebu successfultreatmentofrichtertransformationwithibrutinibinapatientwithchroniclymphocyticleukemiafollowingallogeneichematopoieticstemcelltransplant